Endocrine Status of MG Stroma Alters Breast CA Invasion

MG 基质的内分泌状态改变乳腺 CA 侵袭

基本信息

  • 批准号:
    6514478
  • 负责人:
  • 金额:
    $ 26.62万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2001
  • 资助国家:
    美国
  • 起止时间:
    2001-06-04 至 2005-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The relationship between reproductive history and breast cancer is complex. A full term pregnancy in younger women is protective against breast cancer later in life, while a first full term pregnancy after 40 years of age is associated with higher cancer occurrence. In addition, there is an increase in breast cancer within the first two years of pregnancy, regardless of age. Pregnancy associated breast cancer also presents at a later clinical stage and is more invasive than non-pregnancy associated breast cancers. We hypothesize that the cancer promotional effect of pregnancy is due to physiologic remodeling of the mammary stroma that occurs after pregnancy. During parturition or weaning-induced mammary gland involution, mammary stroma is degraded and stroma levels of matrix metalloproteinases (MMP) and pro-inflammatory mediators are elevated. We propose that these involution-associated changes in mammary stroma promote an epithelial to mesenchymal transition (EMT) in pre-existing neoplastic cells. The resulting activated tumor cells, coupled with the weakened stromal barrier, increases the likelihood of tumor cell extravasation. Since the likelihood of having occult tumor cells increases with age, pregnancy associated gland involution is more likely to effect EMT and metastases in older women. In Aim 1. the hypothesis that tumor cell metastatic potential is modulated by reproductive status will be tested in vivo using xenograft models. Human mammary tumor cells will be injected directly into teats or mammary fat pads of immunodeficient mice at different reproductive stages (i.e. nulliparous, 'pregnancy-associated', and parous). The ability of tumor cells to exit the gland is predicted to be dependent on the degree of tissue remodeling at the time of injection: low in nulliparous and parous, and high in regressing glands. Primary tumors will be evaluated histologically and metastases to lung, liver, brain and long bone of the leg will be measured by semi-quantitative PCR using a unique human sequence, the CCR5 gene. In Aim 2, the hypothesis that endocrine-induced changes in stroma composition can either promote or suppress EMT will be evaluated in vitro using reconstitution models. Human mammary epithelial cells, which differ in metastatic potential from non-tumorigenic to metastatic, will be combined with mammary stroma isolated from rats with different reproductive states. It is anticipated that quiescent mammary stroma (nulliparous and parous) will inhibit, while involuting matrix will promote EMT in highly metastatic cells. Functional evidence for EMT will be obtained by measuring stroma-dependent changes in cell adhesion, motility and invasiveness using modified Boyden chambers assays. Morphological and biochemical evidence for EMT will be evaluated in a 3-dimensional model of tumor formation. The effects of mammary matrix on key markers of EMT, actin fiber organization, and expression of E-cadherin, vimentin, gelsolin and Fspl proteins, will be determined biochemically. In Aim 3, the hypothesis that involuting mammary matrix induces, while nulliparous and parous mammary matrices suppress expression of MMP in tumor cells will be evaluated by reporter gene assays. Luciferase-based reporter constructs containing either the stromelysin (MMP-3), gelatinase A (MMP-2), or gelatinase B (MMP-9) promoters will be tested for activity in tumor cells plated on different mammary matrices. The results of these studies will contribute to our understanding of the effects pregnancy-associated changes in mammary stroma have on breast cancer progression, and should provide insights into epidemiological data describing the dual effect of pregnancy on breast cancer.
说明(由申请人提供):生育关系

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Pepper J Schedin其他文献

Pepper J Schedin的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Pepper J Schedin', 18)}}的其他基金

NSAIDs During Postpartum Involution for Breast Cancer Chemoprevention
产后复健期间使用非甾体抗炎药进行乳腺癌化学预防
  • 批准号:
    10113546
  • 财政年份:
    2013
  • 资助金额:
    $ 26.62万
  • 项目类别:
NSAIDs During Postpartum Involution for Breast Cancer Chemoprevention
产后复健期间使用非甾体抗炎药进行乳腺癌化学预防
  • 批准号:
    10372923
  • 财政年份:
    2013
  • 资助金额:
    $ 26.62万
  • 项目类别:
NSAIDs During Postpartum Involution for Breast Cancer Chemoprevention
产后复健期间使用非甾体抗炎药进行乳腺癌化学预防
  • 批准号:
    10588231
  • 财政年份:
    2013
  • 资助金额:
    $ 26.62万
  • 项目类别:
Endocrine Status of MG Stroma Alters Breast CA Invasion
MG 基质的内分泌状态改变乳腺 CA 侵袭
  • 批准号:
    6752376
  • 财政年份:
    2001
  • 资助金额:
    $ 26.62万
  • 项目类别:
Endocrine Status of MG Stroma Alters Breast CA Invasion
MG 基质的内分泌状态改变乳腺 CA 侵袭
  • 批准号:
    7287605
  • 财政年份:
    2001
  • 资助金额:
    $ 26.62万
  • 项目类别:
Endocrine Status of MG Stroma Alters Breast CA Invasion
MG 基质的内分泌状态改变乳腺 CA 侵袭
  • 批准号:
    6399858
  • 财政年份:
    2001
  • 资助金额:
    $ 26.62万
  • 项目类别:
Endocrine Status of MG Stroma Alters Breast CA Invasion
MG 基质的内分泌状态改变乳腺 CA 侵袭
  • 批准号:
    6633698
  • 财政年份:
    2001
  • 资助金额:
    $ 26.62万
  • 项目类别:
ECM MEDIATORS OF CHEMOPREVENTIVE AGENTS IN THE BREAST
乳房化学预防剂的 ECM 介质
  • 批准号:
    2429908
  • 财政年份:
    1996
  • 资助金额:
    $ 26.62万
  • 项目类别:
ECM MEDIATORS OF CHEMOPREVENTIVE AGENTS IN THE BREAST
乳房化学预防剂的 ECM 介质
  • 批准号:
    2114691
  • 财政年份:
    1996
  • 资助金额:
    $ 26.62万
  • 项目类别:
ECM MEDIATORS OF CHEMOPREVENTIVE AGENTS IN THE BREAST
乳房化学预防剂的 ECM 介质
  • 批准号:
    2895550
  • 财政年份:
    1996
  • 资助金额:
    $ 26.62万
  • 项目类别:

相似海外基金

A novel motility system driven by two classes of bacterial actins MreB
由两类细菌肌动蛋白 MreB 驱动的新型运动系统
  • 批准号:
    22KJ2613
  • 财政年份:
    2023
  • 资助金额:
    $ 26.62万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
The structural basis of plasmid segregation by bacterial actins
细菌肌动蛋白分离质粒的结构基础
  • 批准号:
    342887
  • 财政年份:
    2016
  • 资助金额:
    $ 26.62万
  • 项目类别:
    Operating Grants
The structural basis for plasmid segregation by bacterial actins
细菌肌动蛋白分离质粒的结构基础
  • 批准号:
    278338
  • 财政年份:
    2013
  • 资助金额:
    $ 26.62万
  • 项目类别:
    Operating Grants
Cytoplasmic Actins in Maintenance of Muscle Mitochondria
细胞质肌动蛋白在维持肌肉线粒体中的作用
  • 批准号:
    8505938
  • 财政年份:
    2012
  • 资助金额:
    $ 26.62万
  • 项目类别:
Differential Expression of the Diverse Plant Actins
多种植物肌动蛋白的差异表达
  • 批准号:
    7931495
  • 财政年份:
    2009
  • 资助金额:
    $ 26.62万
  • 项目类别:
Studies on how actins and microtubules are coordinated and its relevancy.
研究肌动蛋白和微管如何协调及其相关性。
  • 批准号:
    19390048
  • 财政年份:
    2007
  • 资助金额:
    $ 26.62万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Suppression of Arabidopsis Reproductive Actins
拟南芥生殖肌动蛋白的抑制
  • 批准号:
    6655612
  • 财政年份:
    2003
  • 资助金额:
    $ 26.62万
  • 项目类别:
Suppression of Arabidopsis Reproductive Actins
拟南芥生殖肌动蛋白的抑制
  • 批准号:
    6546977
  • 财政年份:
    2003
  • 资助金额:
    $ 26.62万
  • 项目类别:
Interaction of myosin with monomeric actins
肌球蛋白与单体肌动蛋白的相互作用
  • 批准号:
    5311554
  • 财政年份:
    2001
  • 资助金额:
    $ 26.62万
  • 项目类别:
    Priority Programmes
STRUCTURE/INTERACTIONS OF ACTINS AND ACTIN-BINDING PROTEIN
肌动蛋白和肌动蛋白结合蛋白的结构/相互作用
  • 批准号:
    6316669
  • 财政年份:
    2000
  • 资助金额:
    $ 26.62万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了